Back

Empagliflozin potently reduces sarcoplasmic Ca leak and increases Ca transient amplitude of human failing ventricular cardiomyocytes

27 August 2018 (09:15 - 09:30)
Organised by:
Congress Presentation Part of: Heart Failure: new targets for treatment Heart Failure ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Julian Mustroph

University Hospital Regensburg, Regensburg (Germany)

5 More presentations in this session

Presentation thumbnail
Angiotensin II-dependent activation of NADPH oxidase 4 contributes to muscle wasting in mice via downregulation of NF-E2-related factor 2
Doctor T. Kadoguchi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Excessive mitochondrial reactive oxygen species emission from circulating blood cells is associated with severity of heart failure and exercise intolerance
Doctor R. Shirakawa (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Positive cardiac inotropy by carvedilol via unique beta-arrestin2-dependent SERCA2a stimulation
Associate Professor A. Lymperopoulos (Fort Lauderdale, US)
Abstract Slides Video
Presentation thumbnail
HECTD3 attenuates cardiac hypertrophy acting as an E3 ligase of SUMO2
Doctor A. Rangrez (Kiel, DE)
Abstract
Presentation thumbnail
RNA methylation in cardiac hypertrophy and heart failure
Mr E. Buchholz (Goettingen, DE)
Abstract

Access the full session

Session thumbnail
Heart Failure: new targets for treatment

The Event

Event poster

ESC Congress 2018

27 August 2018 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Fetal recapitulation and cellular stress in the evolution and progression of heart failure
thumbnail
Congress Session
Heart Failure 2025 highlights
thumbnail
Congress Session
Unspoken aetiologies of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources